simca-p version 14.1 Search Results


simca p  (Umetrics)
86
Umetrics simca p
Simca P, supplied by Umetrics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/simca-p+version+14%2E1/pm38798215-66-10-13?v=Umetrics
Average 86 stars, based on 1 article reviews
simca p - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier
simca software  (Umetrics)
86
Umetrics simca software
Simca Software, supplied by Umetrics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/simca-p+version+14%2E1/pm42112569-116-6-10?v=Umetrics
Average 86 stars, based on 1 article reviews
simca software - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier
simca  (Umetrics)
86
Umetrics simca
Simca, supplied by Umetrics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/simca-p+version+14%2E1/pmc12785313-275-9-12?v=Umetrics
Average 86 stars, based on 1 article reviews
simca - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier
simca program  (Uman Diagnostics)
86
Uman Diagnostics simca program
Simca Program, supplied by Uman Diagnostics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/simca-p+version+14%2E1/10__3390_slash_gastronomy3040020-90-19-23?v=Uman+Diagnostics
Average 86 stars, based on 1 article reviews
simca program - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier
spotfire version 6.0  (TIBCO)
90
TIBCO spotfire version 6.0
Spotfire Version 6.0, supplied by TIBCO, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/simca-p+version+14%2E1/pmc05875996-154-11-15?v=TIBCO
Average 90 stars, based on 1 article reviews
spotfire version 6.0 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
simca software  (MKS Instruments)
90
MKS Instruments simca software
Simca Software, supplied by MKS Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/simca-p+version+14%2E1/pmc10696245-145-19-23?v=MKS+Instruments
Average 90 stars, based on 1 article reviews
simca software - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
opls da model  (Umetrics)
86
Umetrics opls da model
Results of metabolomic experiments in the HUA mouse model. (A) Design of mouse serum metabolomic experiments. <t>(B)</t> <t>OPLS-DA</t> of metabolomes between the control and Dp-3G-treated groups. R2Y(cum) and Q2(cum) were 0.990 and 0.452, respectively, indicating global metabolic changes caused by Dp-3G treatment. (C) Z-score plot depicting differential metabolites between the control and Dp-3G-treated groups. (D) Heatmap illustrating differential metabolites between the control and Dp-3G-treated groups. (E-F) Pathway analysis and enrichment analysis of differential metabolites between the control and Dp-3G-treated groups, respectively. (G) Integrated metabolic network analysis of differential metabolites between the control and Dp-3G-treated groups. Metabolites exhibiting decreased levels in the Dp-3G-treated group compared to the control group are depicted in blue, while those showing increased levels are indicated in red. Within the square boxes, bar graphs illustrate the relative level comparison of these metabolites across groups. * indicates significance compared to the control group, with P < 0.05. The data are shown as mean ± SEM (n = 8, 6, and 3 biological replicates for control, AP-treated, and Dp-3G-treated groups, respectively). Metabolite names enclosed in dashed-line boxes signify the reversal of HUA-associated metabolic alterations including folate reported in the literature by Dp-3G, whereas those in solid-line boxes denote reversal including methionine and proline by both interventions.[ , , ] Abbreviations: Dp-3G: delphinidin-3-glucoside, AP: allopurinol. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Opls Da Model, supplied by Umetrics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/simca-p+version+14%2E1/pmc12869243-200-6-12?v=Umetrics
Average 86 stars, based on 1 article reviews
opls da model - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier
graphpad prism 8.0  (GraphPad Software Inc)
90
GraphPad Software Inc graphpad prism 8.0
Results of metabolomic experiments in the HUA mouse model. (A) Design of mouse serum metabolomic experiments. <t>(B)</t> <t>OPLS-DA</t> of metabolomes between the control and Dp-3G-treated groups. R2Y(cum) and Q2(cum) were 0.990 and 0.452, respectively, indicating global metabolic changes caused by Dp-3G treatment. (C) Z-score plot depicting differential metabolites between the control and Dp-3G-treated groups. (D) Heatmap illustrating differential metabolites between the control and Dp-3G-treated groups. (E-F) Pathway analysis and enrichment analysis of differential metabolites between the control and Dp-3G-treated groups, respectively. (G) Integrated metabolic network analysis of differential metabolites between the control and Dp-3G-treated groups. Metabolites exhibiting decreased levels in the Dp-3G-treated group compared to the control group are depicted in blue, while those showing increased levels are indicated in red. Within the square boxes, bar graphs illustrate the relative level comparison of these metabolites across groups. * indicates significance compared to the control group, with P < 0.05. The data are shown as mean ± SEM (n = 8, 6, and 3 biological replicates for control, AP-treated, and Dp-3G-treated groups, respectively). Metabolite names enclosed in dashed-line boxes signify the reversal of HUA-associated metabolic alterations including folate reported in the literature by Dp-3G, whereas those in solid-line boxes denote reversal including methionine and proline by both interventions.[ , , ] Abbreviations: Dp-3G: delphinidin-3-glucoside, AP: allopurinol. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Graphpad Prism 8.0, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/simca-p+version+14%2E1/pm37028962-4-7-6?v=GraphPad+Software+Inc
Average 90 stars, based on 1 article reviews
graphpad prism 8.0 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
multivariate analyses  (Umetrics)
86
Umetrics multivariate analyses
Results of metabolomic experiments in the HUA mouse model. (A) Design of mouse serum metabolomic experiments. <t>(B)</t> <t>OPLS-DA</t> of metabolomes between the control and Dp-3G-treated groups. R2Y(cum) and Q2(cum) were 0.990 and 0.452, respectively, indicating global metabolic changes caused by Dp-3G treatment. (C) Z-score plot depicting differential metabolites between the control and Dp-3G-treated groups. (D) Heatmap illustrating differential metabolites between the control and Dp-3G-treated groups. (E-F) Pathway analysis and enrichment analysis of differential metabolites between the control and Dp-3G-treated groups, respectively. (G) Integrated metabolic network analysis of differential metabolites between the control and Dp-3G-treated groups. Metabolites exhibiting decreased levels in the Dp-3G-treated group compared to the control group are depicted in blue, while those showing increased levels are indicated in red. Within the square boxes, bar graphs illustrate the relative level comparison of these metabolites across groups. * indicates significance compared to the control group, with P < 0.05. The data are shown as mean ± SEM (n = 8, 6, and 3 biological replicates for control, AP-treated, and Dp-3G-treated groups, respectively). Metabolite names enclosed in dashed-line boxes signify the reversal of HUA-associated metabolic alterations including folate reported in the literature by Dp-3G, whereas those in solid-line boxes denote reversal including methionine and proline by both interventions.[ , , ] Abbreviations: Dp-3G: delphinidin-3-glucoside, AP: allopurinol. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Multivariate Analyses, supplied by Umetrics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/simca-p+version+14%2E1/pmc12497848-130-4-15?v=Umetrics
Average 86 stars, based on 1 article reviews
multivariate analyses - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier
ibm software (version 26.0  (SPSS Inc)
90
SPSS Inc ibm software (version 26.0
Results of metabolomic experiments in the HUA mouse model. (A) Design of mouse serum metabolomic experiments. <t>(B)</t> <t>OPLS-DA</t> of metabolomes between the control and Dp-3G-treated groups. R2Y(cum) and Q2(cum) were 0.990 and 0.452, respectively, indicating global metabolic changes caused by Dp-3G treatment. (C) Z-score plot depicting differential metabolites between the control and Dp-3G-treated groups. (D) Heatmap illustrating differential metabolites between the control and Dp-3G-treated groups. (E-F) Pathway analysis and enrichment analysis of differential metabolites between the control and Dp-3G-treated groups, respectively. (G) Integrated metabolic network analysis of differential metabolites between the control and Dp-3G-treated groups. Metabolites exhibiting decreased levels in the Dp-3G-treated group compared to the control group are depicted in blue, while those showing increased levels are indicated in red. Within the square boxes, bar graphs illustrate the relative level comparison of these metabolites across groups. * indicates significance compared to the control group, with P < 0.05. The data are shown as mean ± SEM (n = 8, 6, and 3 biological replicates for control, AP-treated, and Dp-3G-treated groups, respectively). Metabolite names enclosed in dashed-line boxes signify the reversal of HUA-associated metabolic alterations including folate reported in the literature by Dp-3G, whereas those in solid-line boxes denote reversal including methionine and proline by both interventions.[ , , ] Abbreviations: Dp-3G: delphinidin-3-glucoside, AP: allopurinol. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Ibm Software (Version 26.0, supplied by SPSS Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/simca-p+version+14%2E1/pm39702349-255-30-31?v=SPSS+Inc
Average 90 stars, based on 1 article reviews
ibm software (version 26.0 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
prism version 8  (GraphPad Software Inc)
90
GraphPad Software Inc prism version 8
Results of metabolomic experiments in the HUA mouse model. (A) Design of mouse serum metabolomic experiments. <t>(B)</t> <t>OPLS-DA</t> of metabolomes between the control and Dp-3G-treated groups. R2Y(cum) and Q2(cum) were 0.990 and 0.452, respectively, indicating global metabolic changes caused by Dp-3G treatment. (C) Z-score plot depicting differential metabolites between the control and Dp-3G-treated groups. (D) Heatmap illustrating differential metabolites between the control and Dp-3G-treated groups. (E-F) Pathway analysis and enrichment analysis of differential metabolites between the control and Dp-3G-treated groups, respectively. (G) Integrated metabolic network analysis of differential metabolites between the control and Dp-3G-treated groups. Metabolites exhibiting decreased levels in the Dp-3G-treated group compared to the control group are depicted in blue, while those showing increased levels are indicated in red. Within the square boxes, bar graphs illustrate the relative level comparison of these metabolites across groups. * indicates significance compared to the control group, with P < 0.05. The data are shown as mean ± SEM (n = 8, 6, and 3 biological replicates for control, AP-treated, and Dp-3G-treated groups, respectively). Metabolite names enclosed in dashed-line boxes signify the reversal of HUA-associated metabolic alterations including folate reported in the literature by Dp-3G, whereas those in solid-line boxes denote reversal including methionine and proline by both interventions.[ , , ] Abbreviations: Dp-3G: delphinidin-3-glucoside, AP: allopurinol. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Prism Version 8, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/simca-p+version+14%2E1/pmc11628557-441-19-23?v=GraphPad+Software+Inc
Average 90 stars, based on 1 article reviews
prism version 8 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


Results of metabolomic experiments in the HUA mouse model. (A) Design of mouse serum metabolomic experiments. (B) OPLS-DA of metabolomes between the control and Dp-3G-treated groups. R2Y(cum) and Q2(cum) were 0.990 and 0.452, respectively, indicating global metabolic changes caused by Dp-3G treatment. (C) Z-score plot depicting differential metabolites between the control and Dp-3G-treated groups. (D) Heatmap illustrating differential metabolites between the control and Dp-3G-treated groups. (E-F) Pathway analysis and enrichment analysis of differential metabolites between the control and Dp-3G-treated groups, respectively. (G) Integrated metabolic network analysis of differential metabolites between the control and Dp-3G-treated groups. Metabolites exhibiting decreased levels in the Dp-3G-treated group compared to the control group are depicted in blue, while those showing increased levels are indicated in red. Within the square boxes, bar graphs illustrate the relative level comparison of these metabolites across groups. * indicates significance compared to the control group, with P < 0.05. The data are shown as mean ± SEM (n = 8, 6, and 3 biological replicates for control, AP-treated, and Dp-3G-treated groups, respectively). Metabolite names enclosed in dashed-line boxes signify the reversal of HUA-associated metabolic alterations including folate reported in the literature by Dp-3G, whereas those in solid-line boxes denote reversal including methionine and proline by both interventions.[ , , ] Abbreviations: Dp-3G: delphinidin-3-glucoside, AP: allopurinol. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)

Journal: Journal of Advanced Research

Article Title: Urate-lowering effect of delphinidin-3-glucoside in red kidney beans via binding to the FAD site of the XO enzyme

doi: 10.1016/j.jare.2025.04.022

Figure Lengend Snippet: Results of metabolomic experiments in the HUA mouse model. (A) Design of mouse serum metabolomic experiments. (B) OPLS-DA of metabolomes between the control and Dp-3G-treated groups. R2Y(cum) and Q2(cum) were 0.990 and 0.452, respectively, indicating global metabolic changes caused by Dp-3G treatment. (C) Z-score plot depicting differential metabolites between the control and Dp-3G-treated groups. (D) Heatmap illustrating differential metabolites between the control and Dp-3G-treated groups. (E-F) Pathway analysis and enrichment analysis of differential metabolites between the control and Dp-3G-treated groups, respectively. (G) Integrated metabolic network analysis of differential metabolites between the control and Dp-3G-treated groups. Metabolites exhibiting decreased levels in the Dp-3G-treated group compared to the control group are depicted in blue, while those showing increased levels are indicated in red. Within the square boxes, bar graphs illustrate the relative level comparison of these metabolites across groups. * indicates significance compared to the control group, with P < 0.05. The data are shown as mean ± SEM (n = 8, 6, and 3 biological replicates for control, AP-treated, and Dp-3G-treated groups, respectively). Metabolite names enclosed in dashed-line boxes signify the reversal of HUA-associated metabolic alterations including folate reported in the literature by Dp-3G, whereas those in solid-line boxes denote reversal including methionine and proline by both interventions.[ , , ] Abbreviations: Dp-3G: delphinidin-3-glucoside, AP: allopurinol. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)

Article Snippet: Statistical modeling was performed using the OPLS-DA model in SIMCA-P (Version 14.1, Umetrics).

Techniques: Metabolomic, Control, Comparison